{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T08:37:12Z","timestamp":1775896632455,"version":"3.50.1"},"reference-count":30,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2009,5,28]],"date-time":"2009-05-28T00:00:00Z","timestamp":1243468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2009,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background and Aim:\u2002<\/jats:bold> Stem cell transplantation offers potential gene therapy for brain tumors. However, this approach has received little attention as a treatment for gastrointestinal tumors. In the present study, we explored the possibility of human bone marrow\u2010derived mesenchymal stem cells (hMSC) producing cytosine deaminase (CD), followed by systemic 5\u2010fluorocytosine (5\u2010FC) administration, showing an antitumor effect on a mouse gastric cancer xenograft.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> We first explored the ability of hMSC, coated with fluorescent dye, to migrate to human gastric cancer MKN45 cells <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>. We then used hMSC in which a gene expressed the prodrug\u2010activating enzyme CD, which can convert the prodrug 5\u2010FC into the cytotoxic agent 5\u2010fluorouracil (5\u2010FU), and further investigated the potential of these cells to deliver the CD gene and to reduce tumor growth in nude mice. The migratory capacity of hMSC was confirmed by an <jats:italic>in vitro<\/jats:italic> migration assay, as well as in an <jats:italic>in vivo<\/jats:italic> model of nude mice bearing subcutaneous tumors of MKN45 cells when hMSC were injected.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> The migration ability of hMSC towards MKN45 cells was confirmed by migration assay. Effective conversion of 5\u2010FC to 5\u2010FU by hMSC transfected with the CD gene (CD\u2010hMSC) showed therapeutic anticancer potential in a MKN45 cell co\u2010culture system, as confirmed by thin layer chromatography. Nude mice bearing MKN45 tumors were intravenously injected with CD\u2010hMSC, followed by systemic 5\u2010FC treatment (500\u2003mg\/kg\/day) for 7\u2003days. Tumor volumes and weights of mice injected with CD\u2010hMSC decreased significantly after treatment with 5\u2010FC. However, the 5\u2010FC\u2010treated group without CD\u2010hMSC injection showed neither a decrease in tumor volume nor bodyweight loss.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> The CD\u2010hMSC system showed anticancer therapeutic potential, and minimized the side\u2010effects of 5\u2010FU.<\/jats:p>","DOI":"10.1111\/j.1440-1746.2009.05862.x","type":"journal-article","created":{"date-parts":[[2009,5,28]],"date-time":"2009-05-28T07:31:26Z","timestamp":1243495886000},"page":"1393-1400","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Cytosine deaminase\u2010producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model"],"prefix":"10.1111","volume":"24","author":[{"given":"Mi\u2010Hyeon","family":"You","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang\u2010Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wooyoung","family":"Shim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang\u2010Rim","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangdun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae\u2010Yong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Man","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunsoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang\u2010Uk","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,16]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.55.2.74"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10111"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.5.12.1571"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-4024"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.1239"},{"key":"e_1_2_6_7_2","first-page":"3603","article-title":"Bone marrow\u2010derived mesenchymal stem cells as vehicles for interferon\u2010beta delivery into tumors","volume":"62","author":"Studeny M","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh299"},{"key":"e_1_2_6_9_2","first-page":"4619","article-title":"In\u2010vivo antitumor\u2010activity of 5\u2010Fluorocytosine on human colorectal\u2010carcinoma cells genetically\u2010modified to express cytosine deaminase","volume":"53","author":"Huber BE","year":"1993","journal-title":"Cancer Res."},{"key":"e_1_2_6_10_2","first-page":"5276","article-title":"Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes\u2014paradigm for a prospective cancer control strategy","volume":"46","author":"Moolten FL","year":"1986","journal-title":"Cancer Res."},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/235262a0"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2042.2002.00513.x"},{"key":"e_1_2_6_13_2","first-page":"1503","article-title":"Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5\u2010fluorocytosine and induce protective immunity to wild type tumor","volume":"54","author":"Mullen CA","year":"1994","journal-title":"Cancer Res."},{"key":"e_1_2_6_14_2","first-page":"4144","article-title":"Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5\u2010fluorouracil","volume":"44","author":"Spears CP","year":"1984","journal-title":"Cancer Res."},{"key":"e_1_2_6_15_2","first-page":"450","article-title":"In vivo kinetics of thymidylate synthetase inhibition of 5\u2010fluorouracil\u2010sensitive and \u2010resistant murine colon adenocarcinomas","volume":"42","author":"Spears CP","year":"1982","journal-title":"Cancer Res."},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(90)90056-8"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20501"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100386"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1874"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0301-0082(91)90009-P"},{"key":"e_1_2_6_21_2","first-page":"2856","article-title":"Expression of transforming growth factor beta type II receptor reduces tumorigenicity in human gastric cancer cells","volume":"57","author":"Chang J","year":"1997","journal-title":"Cancer Res."},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh299"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0876"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1997.8.8-985"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh123"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.22-4-625"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2508"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20612"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-04-1193"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2003.09.012"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2005.07.003"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1746.2009.05862.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1746.2009.05862.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T00:01:06Z","timestamp":1697328066000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1746.2009.05862.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["10.1111\/j.1440-1746.2009.05862.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1746.2009.05862.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"2009-08-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}